Search Results

Keeping Track of Blood Counts

Keeping track of blood counts following diagnosis and prior to bone marrow transplantation is important. In addition, if you decide to use Danazol to boost blood counts in the pre-transplant phase, Prof Helmut Hanenberg in the US would very much like you to be part of his long running study into the effects of this […]

http://www.fanconihope.org/families-and-affected-individuals/keeping-track-of-blood-counts/

Oral Hygene and Dental Care

Visiting your Dentist or Ear, Nose and Throat Specialist? Your dentist and ENT specialist play a vital part in the early detection of Head and Neck Squamous Cell Carcinoma (HNSCC). HNSCC are a significant threat for people with FA, regardless of bone marrow transplantation status. Not only is the incidence of HNSCC considerably higher than in the […]

http://www.fanconihope.org/families-and-affected-individuals/medical-advice-from-qualified-medical-sources/oral-hygene-and-dental-care/

Head and Neck Cancers

Prevention, Screening and Treatment Head and neck cancers in Fanconi Anaemia: Fanconi Hope Information Sheet. link Head and Neck Cancer in Fanconi Anemia: Risks, Screenings, Prevention and Treatment Options: Presentation given by Bhuvanesh Singh, MD, PhD, Memorial Sloan-Kettering Cancer Center, New York, NY at Camp Sunshine 2012. download. Also an article in FARF Newsletter #52 (Nov 12), by […]

http://www.fanconihope.org/families-and-affected-individuals/medical-advice-from-qualified-medical-sources/head-and-neck-cancers/

Guidance for Professionals

Guidance for ENT Specialists Head and neck squamous cell carcinoma (HNSCC) is a significant threat for people with FA, regardless of bone marrow transplantation status. Not only is the incidence of HNSCC considerably higher than in the general population (500-700 times higher), patients with FA present with these types of cancers at a younger age […]

http://www.fanconihope.org/clinical-network/guidance-for-professionals/

International FA Gene Therapy Working Group – First Meeting: 2010

International Fanconi Anaemia Gene Therapy Working Group –  “a real platform for the accelerated development of collaborative clinical studies.” Reported in Nature: Molecular Therapy “Stem Cell Gene Therapy for Fanconi Anemia: Report from the 1st International Fanconi Anemia Gene Therapy Working Group Meeting” : Jakub Tolar http://www.nature.com/mt/journal/v19/n7/full/mt201178a.html Full paper Report from First Meeting: November 16th […]

http://www.fanconihope.org/clinical-network/international-fa-gene-therapy-working-group/working-group-1/

Fanconi Hope-Sponsored Research

 2011 Research Fanconi Hope is pleased to announce the award of a £20,000 research grant to Dr Ketan J Patel,  MD, PhD, from the Laboratory of Molecular Biology, Cambridge University towards his ongoing work on a research project entitled:  Reconstituting and Dissecting Monoubiquitination in the FA Tumor Suppressor Pathway. Dr Patel, who is recognised as […]

http://www.fanconihope.org/clinical-network/research/fanconi-hope-sponsored-research/

Information Sheets

Fanconi Hope Information Sheets Information Sheets are being prepared by Fanconi Hope on a number of topics. If you have suggestions for further topics please contact us. Insurance for people with FA. Download. Updated Apr 14. Pre-implantation Genetic Diagnosis (PGD)/HLA-selection/In Vitro Fertilisation in Fanconi Anaemia.  Download Additional vaccinations for FA affected individuals in UK & […]

http://www.fanconihope.org/families-and-affected-individuals/information-sheets/

About Fanconi Anaemia

What is Fanconi Anaemia? FA is a rare, cancer-predisposing disorder affecting about 150 or more families in the UK (the true extent is unknown) manifested by: A variable presence of congenital anomalies in up to 70% of cases (e.g., thumb and kidney abnormalities) Progressive bone marrow failure in childhood usually leading to haematopoietic stem cell […]

http://www.fanconihope.org/families-and-affected-individuals/about-fanconi-anaemia/

Fanconi Anaemia

Fanconi Anaemia is a rare autosomal recessive cancer predisposing disorder affecting about 150 or more families in the UK (the true extent is unknown) manifested by: (1) a variable presence of congenital anomalies in up to 70% (e.g., thumb and kidney abnormalities); (2) progressive bone marrow failure in childhood usually leading to haematopoietic stem cell transplantation […]

http://www.fanconihope.org/clinical-network/fanconi-anaemia/
Translate: